Edmonton, Canada

Peter K Wolfert


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1979-1980

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter K Wolfert

Introduction

Peter K Wolfert is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of chemistry, particularly in the development of processes related to penicillin and cephalosporin synthesis. With a total of 2 patents, his work has had a meaningful impact on pharmaceutical research and development.

Latest Patents

Wolfert's latest patents include a process for preparing 2-acyloxymethylpenams and 3-acyloxycephams. This innovative process involves treating an unsymmetrical azetidinone disulfide with silver oxide, an acid, and iodine to obtain a mixture of valuable compounds. Additionally, he has developed thiazolineazetidinone derivatives, which serve as intermediates in the synthesis of cephalosporins. These compounds are essential for advancing antibiotic research and improving therapeutic options.

Career Highlights

Throughout his career, Wolfert has demonstrated a commitment to advancing chemical processes that enhance the efficacy of antibiotics. His work has been instrumental in refining methods that are crucial for the pharmaceutical industry. By focusing on the synthesis of complex compounds, he has contributed to the development of new medications that can combat bacterial infections.

Collaborations

Wolfert has collaborated with esteemed colleagues such as Nicholas Darby and Ronald G Micetich. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of chemistry.

Conclusion

Peter K Wolfert's contributions to the field of chemistry through his patents and collaborative efforts highlight his role as a significant inventor. His work continues to influence the pharmaceutical industry and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…